Skip to main content

COVID-19: An Overview

  • Chapter
  • First Online:
  • 325 Accesses

Abstract

The coronavirus disease 2019 (COVID-19) is a viral infection caused by a novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which has emerged as a global pandemic leading to a massive loss of human life worldwide due to its high transmissibility.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. SARS-CoV-2 variants of concern and variants under investigation in England. Technical briefing 31. December 10, 2021. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1040076/Technical_Briefing_31.pdf. Accessed on December 13, 2021.

  2. SARS-CoV-2 variants of concern and variants under investigation. 33.

    Google Scholar 

  3. Li D, Jin M, Bao P, Zhao W, Zhang S. Clinical characteristics and results of semen tests among men with coronavirus disease 2019. JAMA Netw Open. 2020;3:e208292.

    Article  PubMed  PubMed Central  Google Scholar 

  4. CDC. Quarantine & isolation [Internet]. Centers for disease control and prevention 2022 [cited 2022 Apr 15]; Available from: https://www.cdc.gov/coronavirus/2019-ncov/your-health/quarantine-isolation.html

  5. Ma Q, Liu J, Liu Q, Kang L, Liu R, Jing W, et al. Global percentage of asymptomatic SARS-CoV-2 infections among the tested population and individuals with confirmed COVID-19 diagnosis: a systematic review and meta-analysis. JAMA Netw Open. 2021;4:e2137257.

    Article  PubMed  PubMed Central  Google Scholar 

  6. CDC. Healthcare Workers [Internet]. Centers for disease control and prevention 2020 [cited 2022 Apr 15]; Available from: https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-management-patients.html

  7. Clinical features of covid-19 | The BMJ [Internet]. [cited 2022 Apr 15]; Available from: https://www.bmj.com/content/369/bmj.m1470/rapid-responses

  8. Serum troponin, D-dimer, and CRP level in severe coronavirus (COVID-19) patients–PubMed [Internet]. [cited 2022 Apr 15]; Available from: https://pubmed.ncbi.nlm.nih.gov/34939346/

  9. Dinnes J, Deeks JJ, Adriano A, Berhane S, Davenport C, Dittrich S, et al. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection. Cochrane Database Syst Rev. 2020;8:CD013705.

    PubMed  Google Scholar 

  10. Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab | NEJM [Internet]. [cited 2022 Apr 15]; Available from: https://www.nejm.org/doi/full/10.1056/NEJMoa2107934

  11. CDC. Cases, Data, and Surveillance [Internet]. Centers for Disease Control and Prevention 2020 [cited 2022 May 25]; Available from: https://www.cdc.gov/coronavirus/2019-ncov/covid-data/investigations-discovery/assessing-risk-factors.html

  12. Concomitant Medications [Internet]. COVID-19 Treatment Guidelines [cited 2022 Apr 20]; Available from: https://www.covid19treatmentguidelines.nih.gov/therapies/concomitant-medications/

  13. Marshall JC, Murthy S, Diaz J, Adhikari NK, Angus DC, Arabi YM, et al. A minimal common outcome measure set for COVID-19 clinical research. Lancet Infect Dis. 2020;20:e192–7.

    Article  CAS  Google Scholar 

  14. Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27:601–15.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Moorjani, H., Gupta, S.K. (2022). COVID-19: An Overview. In: Mohan, A., Mittal, S. (eds) Post COVID-19 Complications and Management. Springer, Singapore. https://doi.org/10.1007/978-981-19-4407-9_1

Download citation

  • DOI: https://doi.org/10.1007/978-981-19-4407-9_1

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-19-4406-2

  • Online ISBN: 978-981-19-4407-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics